(Q113892385)
Statements
A Phase 2 Study of Pyrotinib in Patients With Advanced/ Metastatic HER2-Altered Biliary Tract Cancers Who Have Failed One or Two Prior Lines of Therapies (English)
0 references
1 November 2020
0 references
1 May 2022
0 references
70
0 references
18 year
0 references